ENTRY       D12254                      Drug
NAME        Amubarvimab (USAN)
FORMULA     C6378H9906N1710O2010S40
EXACT_MASS  143893.4325
MOL_WEIGHT  143981.7492
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGITVS SNYMNWVRQA PGKGLEWVSL IYSGGSTYYA
            DSVKGRFTIS RDNSKNTLYL QMNSLRAEDT AVYHCARDLV VYGMDVWGQG TTVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LYITREPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPTFGQ GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H114-H200, H220-L214, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'95, H'144-H'200, H'220-L'214, H'261-H'321, H'367-H'425, L23-L89, L134-L194, L'23-L'89, L'134-L'194)
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of COVID-19
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12254  Amubarvimab
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12254  Amubarvimab (USAN)
DBLINKS     CAS: 2509447-07-6
///
